New research might have you encouraging residents and staff members worried about their heart health to cut back on soda consumption but not to worry about taking NSAIDs such as aspirin and ibuprofen.
Social determinants of health tied to atherosclerotic CVD risk
May 01, 2024
The authors say that social determinants could increase the prediction ability of risk tools, particularly for Black patients.
Declines in CVD mortality seen from 2010 to 2019 reversed in 2020
Jan 26, 2024
From 2020 to 2022, there were 228,524 excess cardiovascular deaths, which was 9% more than expected based on earlier trends.
Black-white disparities persist for cardiovascular mortality
Aug 03, 2022
Two studies show increased cardiovascular mortality for Black versus white adults in a nationwide analysis and the MESA sample.
USPSTF still says individualize decision for diet, exercise counseling
Jul 26, 2022
“When determining which patients might benefit from counseling interventions, healthcare professionals should consider the patient’s goals and motivations, activity and ability,” a task...
Antiseizure treatment explored in comatose cardiac arrest survivors
Feb 25, 2022
A strategy to suppress rhythmic and periodic EEG patterns did not improve neurologic outcomes at three months.
Rates of adverse events lower with pixaban for A-fib in older adults
Jul 20, 2021
Apixaban was the only direct oral anticoagulant linked to lower adverse event rates than warfarin for patients with atrial fibrillation across frailty levels.
USPSTF: Individualize counseling for primary prevention of cardiovascular disease
Jan 18, 2022
For adults without known CVD risk factors, individualize the decision to refer to behavioral counseling to promote healthy diet and physical activity.
USPSTF advises against starting aspirin in ≥60s to prevent CVD
Oct 12, 2021
The U.S. Preventive Services Task Force (USPSTF) recommends against initiating use of aspirin for the primary prevention of cardiovascular disease (CVD) for adults aged 60 years or older.
Screening seniors for a-fib reduces risk for adverse outcomes
Sep 01, 2021
A reduction was seen in combined end point of stroke, systemic embolism, bleeding leading to hospitalization, and death.